[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2710840B1 - Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique. - Google Patents

Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.

Info

Publication number
FR2710840B1
FR2710840B1 FR9311786A FR9311786A FR2710840B1 FR 2710840 B1 FR2710840 B1 FR 2710840B1 FR 9311786 A FR9311786 A FR 9311786A FR 9311786 A FR9311786 A FR 9311786A FR 2710840 B1 FR2710840 B1 FR 2710840B1
Authority
FR
France
Prior art keywords
medical
preparation
highly concentrated
fluorinated compounds
cosmetic fields
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9311786A
Other languages
English (en)
Other versions
FR2710840A1 (fr
Inventor
Marie-Pierre Krafft
Jean G Riess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
APPLIC TRANSFERTS TECHNOLO
Original Assignee
APPLIC TRANSFERTS TECHNOLO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9311786A priority Critical patent/FR2710840B1/fr
Application filed by APPLIC TRANSFERTS TECHNOLO filed Critical APPLIC TRANSFERTS TECHNOLO
Priority to ES94929508T priority patent/ES2134359T3/es
Priority to CA002173321A priority patent/CA2173321A1/fr
Priority to AT94929508T priority patent/ATE179884T1/de
Priority to PCT/EP1994/003276 priority patent/WO1995009606A1/fr
Priority to AU78541/94A priority patent/AU688800B2/en
Priority to EP94929508A priority patent/EP0722313B1/fr
Priority to JP7510609A priority patent/JPH09503802A/ja
Priority to DE69418468T priority patent/DE69418468T2/de
Priority to DK94929508T priority patent/DK0722313T3/da
Priority to US08/316,731 priority patent/US5573757A/en
Publication of FR2710840A1 publication Critical patent/FR2710840A1/fr
Application granted granted Critical
Publication of FR2710840B1 publication Critical patent/FR2710840B1/fr
Priority to GR990401604T priority patent/GR3030528T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
FR9311786A 1993-10-04 1993-10-04 Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique. Expired - Fee Related FR2710840B1 (fr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FR9311786A FR2710840B1 (fr) 1993-10-04 1993-10-04 Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.
DE69418468T DE69418468T2 (de) 1993-10-04 1994-10-01 Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen
AT94929508T ATE179884T1 (de) 1993-10-04 1994-10-01 Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen
PCT/EP1994/003276 WO1995009606A1 (fr) 1993-10-04 1994-10-01 Compositions viscoelastiques de composes organiques fluores
AU78541/94A AU688800B2 (en) 1993-10-04 1994-10-01 Viscoelastic compositions of fluorinated organic compounds
EP94929508A EP0722313B1 (fr) 1993-10-04 1994-10-01 Compositions viscoelastiques de composes organiques fluores
ES94929508T ES2134359T3 (es) 1993-10-04 1994-10-01 Composiciones viscoelasticas de compuestos organicos fluorados.
CA002173321A CA2173321A1 (fr) 1993-10-04 1994-10-01 Compositions viscoelastiques de composes organiques fluores
DK94929508T DK0722313T3 (da) 1993-10-04 1994-10-01 Viskoelastiske sammensætninger af fluorerede organiske forbindelser
JP7510609A JPH09503802A (ja) 1993-10-04 1994-10-01 フッ素化有機化合物の粘弾性組成物
US08/316,731 US5573757A (en) 1993-10-04 1994-10-03 Viscoelastic compositions containing concentrated fluorinated compounds their method of preparation and their uses
GR990401604T GR3030528T3 (en) 1993-10-04 1999-06-16 Viscoelastic compositions of fluorinated organic compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9311786A FR2710840B1 (fr) 1993-10-04 1993-10-04 Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.

Publications (2)

Publication Number Publication Date
FR2710840A1 FR2710840A1 (fr) 1995-04-14
FR2710840B1 true FR2710840B1 (fr) 1995-12-01

Family

ID=9451507

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9311786A Expired - Fee Related FR2710840B1 (fr) 1993-10-04 1993-10-04 Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.

Country Status (12)

Country Link
US (1) US5573757A (fr)
EP (1) EP0722313B1 (fr)
JP (1) JPH09503802A (fr)
AT (1) ATE179884T1 (fr)
AU (1) AU688800B2 (fr)
CA (1) CA2173321A1 (fr)
DE (1) DE69418468T2 (fr)
DK (1) DK0722313T3 (fr)
ES (1) ES2134359T3 (fr)
FR (1) FR2710840B1 (fr)
GR (1) GR3030528T3 (fr)
WO (1) WO1995009606A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737135B1 (fr) * 1995-07-24 1997-09-12 Atta Gels inverses a phase continue fluoree
FR2737972B1 (fr) * 1995-08-24 1997-09-26 Oreal Emulsion ayant une texture aeree
US5733526A (en) * 1995-12-14 1998-03-31 Alliance Pharmaceutical Corp. Hydrocarbon oil/fluorochemical preparations and methods of use
US5980936A (en) * 1997-08-07 1999-11-09 Alliance Pharmaceutical Corp. Multiple emulsions comprising a hydrophobic continuous phase
DE19926889B4 (de) 1999-06-12 2005-06-16 Bausch & Lomb Inc. Verwendung eines Gels mit Polyaphronstruktur zur Herstellung eines Implantats
DE19938668B4 (de) * 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
EP1306083A4 (fr) * 2000-07-20 2007-08-29 Perftoran West Ltd Emulsion de composes organiques perfluores utilises a des fins medicales, procede de fabrication et procedes de traitement et de prevention des maladies au moyen de cette emulsion
DE60134657D1 (de) 2000-09-26 2008-08-14 Univ North Carolina Phosphat-fluortenside zur verwendung in kohlendioxid
US7357937B2 (en) * 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
EP1684716A4 (fr) * 2003-11-05 2009-04-22 Univ Australian Dispersions et leurs procedes de preparation
DE10358306B8 (de) 2003-12-08 2005-03-03 Coty B.V. Kosmetisches und dermatologisches Sauerstoff-Trägersystem, Verfahren zu dessen Herstellung sowie seine Verwendung
ES2552233T3 (es) * 2004-10-20 2015-11-26 Ethicon, Inc. Hemostato absorbible
US9358318B2 (en) * 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
US20060257457A1 (en) * 2004-10-20 2006-11-16 Gorman Anne J Method for making a reinforced absorbable multilayered hemostatic wound dressing
AR054805A1 (es) * 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
JP4902162B2 (ja) * 2005-09-26 2012-03-21 日油株式会社 複合材料成形物及びその製造方法
ES2325274T3 (es) * 2005-10-20 2009-08-31 Filippo Ernestino Parodi Utilizacion de colageno en combinacion con perfluorocarbonos que liberan oxigeno y ozono para la preparacion de un medicamento para el tratamiento de lesiones cutaneas.
WO2007092312A2 (fr) 2006-02-03 2007-08-16 Stiefel Laboratories, Inc. Compositions pour traitement cutane topique
EP2206494B1 (fr) 2006-03-31 2015-12-02 Stiefel Research Australia Pty Ltd Gel de suspension moussable
EP1970048A1 (fr) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Composition topique de type polyaphron avec de la vitamine D
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (fr) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Patch bioérodable
JP5142267B2 (ja) * 2008-03-04 2013-02-13 独立行政法人産業技術総合研究所 短鎖両性界面活性剤
US8343515B2 (en) * 2008-11-25 2013-01-01 Oxygen Biotherapeutics, Inc. Perfluorocarbon gel formulations
EP2686017B1 (fr) 2011-03-14 2019-07-03 Drug Delivery Solutions Limited Composition ophtalmique
GB201701583D0 (en) * 2017-01-31 2017-03-15 Drug Delivery Solutions Ltd Topical composition
EP3542788A1 (fr) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Composition topique comprenant calcipotriol et dipropionate de bétaméthasone
CA3105417A1 (fr) 2018-07-31 2020-02-06 MC2 Therapeutics Limited Composition comprenant une phase aqueuse continue, une phase huileuse fluide discontinue et un crisaborole

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0031353B1 (fr) * 1979-06-25 1984-08-08 Suntech, Inc. Utilisation de carbone perfluore pour le traitement des brulures
US4569784A (en) * 1980-11-17 1986-02-11 Adamantech, Inc. Preparation of a gel having gas transporting capability
US4423077A (en) * 1982-07-27 1983-12-27 The University Of Pennsylvania Perfluorochemical emulsion artificial blood
US4917930A (en) * 1984-04-16 1990-04-17 Adamantech, Inc. Perfluoro compound dispersions containing reduced amounts of surfactant and process of preparation
CA1257828A (fr) * 1984-04-16 1989-07-25 William Mccormick Dispersions de compose perfluore renfermant des quantites reduites de surfactif; methode de preparation
IL84911A (en) * 1987-12-22 1993-04-04 Yissum Res Dev Co Processes for the preparation of collagen products, and pharmaceutical compositions containing the same
US5185099A (en) * 1988-04-20 1993-02-09 Institut National De Recherche Chimique Appliquee Visco-elastic, isotropic materials based on water, fluorinate sufactants and fluorinated oils, process for their preparation, and their use in various fields, such as optics, pharmacology and electrodynamics
FR2630347B1 (fr) * 1988-04-20 1991-08-30 Inst Nat Rech Chimique Materiaux viscoelastiques isotropes a base d'eau, de tensioactifs fluores et d'huiles fluorees, leur procede d'obtention et leurs applications dans divers domaines, tels que ceux de l'optique, de la pharmacologie et de l'electrodynamique
DK0478686T3 (da) * 1989-06-22 1993-11-29 Alliance Pharma Flour- og phosphorholdige amphiphile molekyler med overfladeaktive egenskaber
FR2679150A1 (fr) * 1991-07-17 1993-01-22 Atta Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
US5264220A (en) * 1991-11-12 1993-11-23 Long David M Jr Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
US5304325A (en) * 1991-11-13 1994-04-19 Hemagen/Pfc Emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use

Also Published As

Publication number Publication date
DE69418468T2 (de) 1999-10-07
GR3030528T3 (en) 1999-10-29
US5573757A (en) 1996-11-12
CA2173321A1 (fr) 1995-04-13
DE69418468D1 (de) 1999-06-17
JPH09503802A (ja) 1997-04-15
EP0722313B1 (fr) 1999-05-12
AU688800B2 (en) 1998-03-19
DK0722313T3 (da) 1999-11-15
ES2134359T3 (es) 1999-10-01
WO1995009606A1 (fr) 1995-04-13
AU7854194A (en) 1995-05-01
FR2710840A1 (fr) 1995-04-14
ATE179884T1 (de) 1999-05-15
EP0722313A1 (fr) 1996-07-24

Similar Documents

Publication Publication Date Title
FR2710840B1 (fr) Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.
CS653586A3 (en) Pharmaceutical containing 7-isopropoxyisoflavone
HUP0001094A2 (hu) Eljárás naloxon és sói stabilizálására, és naloxont tartalmazó, stabilizált gyógyszerkészítmények
KR920021139A (ko) 약학 조성물
DK0902789T3 (da) Androstenderivater
DE3669106D1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
MX9400801A (es) Agentes colinergicos de oxima de tetrahidropiridinna o-substituidos estabilizados con almidon.
ATE104863T1 (de) Pharmazeutische formulierung von plasminogenaktivatorproteinen.
US3230143A (en) Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine
FR2712809B1 (fr) Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
KR930001903A (ko) 유비데카레논 경구용 수용액 제제
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
KR880007068A (ko) 13-시스 레티노산의 용도
US4837213A (en) Pharmaceutical vehicle for active substances in the form of an anhydrous gel
ATE34662T1 (de) Derivate der benzoesaeure, herstellungsverfahren und anwendung in desinfizierenden und konservierenden arzneimitteln.
SE9403905D0 (sv) New formulations
JPH03120230A (ja) 薬効成分の経皮吸収促進剤及び経皮吸収型製剤
ATE201137T1 (de) Halbfeste pharmazeutische zubereitungen enthaltend dexketoprofen-trometamol
DK0647129T3 (da) Præparat til topisk anvendelse
US5034420A (en) Compositions and method for stabilization of anthralin comprising the addition of an oil soluble antioxidant and an anionic surfactant
ES2179667T3 (es) Nuevas formulaciones inyectables que contienen ramoplanina.
GB2142534A (en) Stabilization of compositions with anionic surfactant
KR930012023A (ko) 환원된 형태의 비글리코실화 재조합 인체 il2의 안정화된 제약 조성물 및 그의 제조방법
KR950701216A (ko) 레마세미드의 파킨슨병 치료 용도(use of remacemide for the treatment of parkinson's disease)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse